Recent developments in DNA topoisomerase II structure and mechanism

https://doi.org/10.1016/S0959-440X(96)80099-6Get rights and content

Abstract

Type II DNA topoisomerases are enzymes that are capable of transporting one duplex DNA through another. Recent experimental results, including the structure of a fragment of yeast topoisomerase II, have provided new insights into the mechanism of the strand passage reaction. Other results have begun to define the role of ATP in the catalytic cycle and illuminate how DNA breaks mediated by topoisomerase II can occur.

References (67)

  • JE Lindsley et al.

    On the coupling between ATP usage and DNA transport by yeast DNA topoisomerase II

    J Biol Chem

    (1993)
  • JE Lindsley et al.

    Study of allosteric communication between promoters by immunotagging

    Nature

    (1993)
  • K Mizuuchi et al.

    DNA gyrase: subunit structure and ATPase activity of the purified enzyme

    Proc Natl Acad Sci USA

    (1978)
  • JR Roca et al.

    The capture of a DNA double helix by an ATP-dependent protein clamp: a key step in DNA transport by type II DNA topoisomerases

    Cell

    (1992)
  • DB Wigley et al.

    Crystal structure of an N-terminal fragment of the DNA gyrase B protein

    Nature

    (1991)
  • G Orphanides et al.

    Evidence for a conformational change in the DNA gyrase—DNA complex from hydroxyl radical footprinting

    Nucleic Acids Res

    (1994)
  • H Peng et al.

    The interaction of Escherichia coli topoisomerase IV with DNA

    J Biol Chem

    (1995)
  • CH Freudenreich et al.

    Mutational analysis of a type II topoisomerase cleavage site: distinct requirements for enzyme and inhibitors

    EMBO J

    (1993)
  • LF Liu et al.

    DNA—DNA gyrase complex: the wrapping of the DNA duplex outside the enzyme

    Cell

    (1978)
  • K Kirkegaard et al.

    Mapping the topography of DNA wrapped around gyrase by nucleolytic and chemical probing of complexes of unique DNA sequences

    Cell

    (1981)
  • DS Horowitz et al.

    Mapping the active site of Escherichia coli DNA gyrase

    J Biol Chem

    (1987)
  • ST Worland et al.

    Inducible overexpression, purification and active-site mapping of DNA topoisomerase II from yeast Saccharomyces cerevisiae

    J Biol Chem

    (1989)
  • JQ Svejstrup et al.

    Techniques to uncouple DNA binding, cleavage and religation in the catalytic cycles of eukaryotic topoisomerase I and II

  • AH Andersen et al.

    Studies of the topoisomerase II-mediated cleavage and religation reactions by use of a suicidal double-stranded DNA substrate

    J Biol Chem

    (1991)
  • PS Kingma et al.

    Abasic sites stimulate double-strand DNA cleavage mediated by topoisomerase II

    J Biol Chem

    (1995)
  • JM Berger et al.

    Structure at 2.7 Å of a 92 K yeast topoisomerase II fragment

    Nature

    (1996)
  • V Frere et al.

    A peptide fragment of human DNA topoisomerase II α forms a stable coiled-coil structure in solution

    J Biol Chem

    (1995)
  • M Carson

    Ribbons 2.0

    J Appl Crystallogr

    (1991)
  • PO Brown et al.

    A sign inversion mechanism for enzymatic supercoiling of DNA

    Science

    (1979)
  • JC Wang

    DNA topoisomerases

    Annu Rev Biochem

    (1985)
  • M Gellert

    DNA topoisomerases

    Annu Rev Biochem

    (1981)
  • T Hsieh

    Mechanistic aspects of type II DNA topoisomerases

  • M Yanagida et al.

    Genetics of DNA topoisomerases

  • Cited by (103)

    • Recent development of multi-targeted inhibitors of human topoisomerase II enzyme as potent cancer therapeutics

      2023, International Journal of Biological Macromolecules
      Citation Excerpt :

      Results revealed that topoisomerase IIα (3′-hydroxydaunorubicin and the ohlivacine derivative) eliminates Ras-positive oncogenes but not the wild [73]. In another related investigation, another group of scientists found that merbarone causes apoptosis activating caspase3-like protease in drug-sensitive CEM cell lines and ICRF-187 in CEM drug resistance without activating JNK1 [43,44]. Another multi-targeting investigation done by Ma et al. 2016 suggests that a bis-fluoroquinolone chalcone-like derivative (HMNE3) inhibits the activity of both tyrosine kinases and topoisomerase II and causes apoptosis in cancer cells [43].

    • Natural bioactive lead compounds effective against haematological malignancies

      2019, Phytochemicals as Lead Compounds for New Drug Discovery
    • Natural bioactive lead compounds effective against haematological malignancies

      2019, Phytochemicals as Lead Compounds for New Drug Discovery
    View all citing articles on Scopus
    View full text